![Christopher Brennan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Relaciones activas
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Mark Goldberg | M | 64 |
Allucent
![]() Allucent Pharmaceuticals: OtherHealth Technology Allucent is a clinical research organization that provides comprehensive drug development solutions to small and mid-sized biotech companies. The private company is based in Cary, NC, and was founded in 2022. With over 30 years of experience in more than 60 countries, the company offers consulting, clinical operations, biometrics, and clinical pharmacology services across various therapeutic areas. Allucent's individualized partnership approach provides experience-driven insights and expertise to assist its clients in successfully navigating the complexities of delivering novel treatments to patients. Mark A. Goldberg has been the CEO of the company since 2018. | 6 años |
Gráfico relacional
Relaciones con varias empresas
Estadísticas
País | Relaciones | % del total |
---|---|---|
Estados Unidos | 1 | 100.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Christopher Brennan
- Red Personal